本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Revolution Medicines, Inc.

183.86
-4.2100-2.24%
盤後183.00-0.8600-0.47%19:28 EDT
成交量:240.15萬
成交額:4.41億
市值:390.87億
市盈率:-25.82
高:188.68
開:186.60
低:181.49
收:188.07
52周最高:194.56
52周最低:34.00
股本:2.13億
流通股本:2.00億
量比:1.47
換手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-7.1214
每股收益(LYR):-5.9502
淨資產收益率:-76.67%
總資產收益率:-37.53%
市淨率:26.06
市盈率(LYR):-30.90

資料載入中...

2026/06/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/22

重要事件披露

Form 8-K - Current report
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/27

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/15

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses